Intramuscular Ceftriaxone for Community-Acquired Pneumonia
For adults with community-acquired pneumonia requiring intramuscular therapy, administer ceftriaxone 1 gram IM once daily for 4-14 days (typically 5-7 days for uncomplicated cases), combined with a macrolide such as azithromycin 500 mg daily. 1, 2
Dosing Specifics
The FDA-approved dosing for adults is 1-2 grams once daily, with the total daily dose not exceeding 4 grams 2. However, the evidence strongly supports that:
- 1 gram daily is sufficient for most CAP cases and is associated with similar mortality outcomes compared to 2 grams daily 3
- The 1 gram dose maintains bactericidal concentrations above the MIC for common respiratory pathogens (S. pneumoniae, H. influenzae, M. catarrhalis) for the entire 24-hour dosing period 4, 5
- Lower doses reduce adverse events, particularly C. difficile infection (0.2% vs 0.6% with 2g) and result in shorter hospital stays 3
When to Use 2 Grams Daily
Consider escalating to 2 grams once daily only for:
- Severe pneumonia requiring mechanical ventilation (associated with 3.2% absolute mortality reduction) 6
- Documented or suspected highly resistant organisms
- Patients not responding to 1 gram within 48-72 hours
Combination Therapy is Mandatory
Never use ceftriaxone monotherapy for CAP. The 2019 ATS/IDSA guidelines provide a strong recommendation for combination therapy 1:
- Ceftriaxone 1-2g daily PLUS azithromycin 500mg daily (strong recommendation, high-quality evidence)
- Alternative: Ceftriaxone plus clarithromycin 500mg twice daily
- If macrolide contraindicated: Ceftriaxone plus doxycycline 100mg twice daily (conditional recommendation, low-quality evidence)
This combination is essential because ceftriaxone lacks activity against atypical pathogens (Mycoplasma, Chlamydia, Legionella) that commonly cause CAP 1.
Duration of Therapy
Continue treatment for at least 2 days after clinical improvement (resolution of fever, improved respiratory symptoms, stable vital signs) 2. The typical duration is:
- Uncomplicated CAP: 5-7 days (usual range 4-14 days)
- Streptococcus pyogenes infection: minimum 10 days
- Complicated infections: may require longer therapy 2
Administration Technique
For IM injection 2:
- Reconstitute 1g vial with 3.6 mL diluent to achieve 250 mg/mL concentration
- Inject deeply into a large muscle mass (gluteal or lateral thigh)
- Aspirate before injection to avoid inadvertent intravascular administration
- Peak serum concentrations occur at 2-3 hours post-injection 2
Key Clinical Considerations
Pharmacokinetic advantages of IM route:
- IM administration achieves therapeutic levels comparable to IV by 2.5 hours 5
- Maintains bactericidal concentrations for 24 hours with once-daily dosing 7, 4
- Excellent penetration into pleural fluid and respiratory tissues 7
- Cost-effective alternative to IV therapy for outpatient or nursing home settings 8
Critical contraindications:
- Neonates ≤28 days (risk of bilirubin encephalopathy and calcium precipitation) 2
- Concurrent calcium-containing IV solutions (risk of fatal precipitation) 2
- Hyperbilirubinemic patients require caution
Common pitfall: Do not use ceftriaxone alone for suspected MRSA or Pseudomonas aeruginosa pneumonia—these require different empiric regimens 1.
No Dose Adjustment Needed
Renal or hepatic impairment does not require dose adjustment up to 2 grams daily, and elderly patients require no modification if renal/hepatic function is preserved 2.